News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canopus BioPharma, Inc. Engages Pullan Consulting to Commence the Formation of Drug Development and Licensing Partnerships



5/1/2008 9:34:13 AM

LOS ANGELES--(BUSINESS WIRE)--Canopus BioPharma, Inc. (OTCPK: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer, and addiction, announced today that it has engaged Pullan Consulting to identify and enter into drug development and licensing partnerships with large pharmaceutical companies. Pullan Consulting is a California-based biotech business development consulting firm led by Linda Pullan, Ph.D., which has served over 20 emerging and later stage pharmaceutical companies since being established in 2006.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES